Warren Buffett's Berkshire Hathaway is Friday's IBD Stock Of The Day as the massive conglomerate, which is reportedly in ...

The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...

Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...

IBD affects millions of Americans. It's estimated that 130,000 adults and children in New England are living with the disease ...

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments ...

A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.

A team of researchers has unveiled a revolutionary ingestible bioimpedance sensing device capable of continuously and ...

Individuals’ metabolomic marker profiles may predict the onset of inflammatory bowel disease a decade in advance, underlining ...

There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization.

This innovative project aims to enhance remote monitoring and enable early detection of IBD flares through digital biomarkers ...